Phase 4 N=67 Randomized Treatment

Evaluation of Biocleanse Allografts For ACL Reconstruction

Anterior Cruciate Ligament Tear

Bottom Line

View on ClinicalTrials.gov: NCT00187876 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2014

Primary outcome: Primary: International Knee Documentation Committee (IKDC) Form — 89; 88 score

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: ACL reconstruction control (Procedure); ACL Biocleanse, surgical (Procedure)
Age: Adult · 18+ yrs
Sex: All
Sponsor: University of Florida
Primary completion: Dec 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY International Knee Documentation Committee (IKDC) Form	89; 88	—

Summary

The purpose of this study is to determine the efficacy of patellar tendon allografts that have undergone the BioCleanse™ process.

Eligibility Criteria

Inclusion Criteria

ACL reconstruction

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00187876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.